- Report
- September 2026
- 188 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 188 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 191 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 194 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- January 2026
- 190 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- February 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,507GBP
- Report
- February 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,507GBP
- Report
- July 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,507GBP
- Report
- May 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,507GBP
- Report
- February 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,507GBP
- Report
- September 2026
- 489 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- September 2026
- 213 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- September 2026
- 395 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- September 2026
- 317 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- July 2026
- 150 Pages
Global
From €3407EUR$3,750USD£2,929GBP
- Report
- August 2026
- 115 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- August 2026
- 110 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- July 2026
- 114 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- July 2026
- 110 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- June 2026
- 180 Pages
Global
From €4316EUR$4,750USD£3,710GBP

The Molecular Assay market within the In Vitro Diagnostics (IVD) industry is a rapidly growing segment. It is composed of a variety of technologies and products used to detect and measure the presence of specific molecules in biological samples. These assays are used to diagnose and monitor diseases, detect genetic mutations, and identify infectious agents. Molecular assays are also used in research and drug development.
Molecular assays are typically performed in laboratories, but there is an increasing trend towards point-of-care testing. This allows for faster results and improved patient outcomes. Additionally, the development of new technologies such as next-generation sequencing and digital PCR are driving the growth of the molecular assay market.
Notable companies in the Molecular Assay market include Abbott, Becton Dickinson, Roche, Siemens Healthineers, Thermo Fisher Scientific, and Qiagen. Show Less Read more